Evidence map›Paper›PMID 36271707›Full record

ArticleVirulence2022

Ohmyungsamycin promotes M1-like inflammatory responses to enhance host defence against

Sang Min Jeon, Young Jae Kim, Thanh Quang Nguyen, Jinsheng Cui, Bui Thi Bich Hanh, Prashanta Silwal, Jin Kyung Kim, Jin-Man Kim, Dong-Chan Oh, Jichan Jang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Sang Min JeonDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.ORCID 0000-0002-7576-414X
Young Jae KimDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.ORCID 0000-0003-0035-037X
Thanh Quang NguyenDivision of Life Science, Department of Bio & Medical Big Data (BK21 Four Program), Research Institute of Life Science, Gyeongsang National University, Jinju, South Korea.
Jinsheng CuiNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.ORCID 0000-0001-6078-6023
Bui Thi Bich HanhDivision of Applied Life Science (BK21 Four Program), Research Institute of Life Science, Gyeongsang National University, Jinju, South Korea.
Prashanta SilwalDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.ORCID 0000-0002-8332-024X
Jin Kyung KimDepartment of Microbiology, Keimyung University School of Medicine, Daegu, South Korea.ORCID 0000-0002-2051-5787
Jin-Man KimInfection Control Convergence Research Center, Chungnam National University School of Medicine, Daejeon, South Korea.ORCID 0000-0003-0905-9730
Dong-Chan OhNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, South Korea.ORCID 0000-0001-6405-5535
Jichan JangDivision of Life Science, Department of Bio & Medical Big Data (BK21 Four Program), Research Institute of Life Science, Gyeongsang National University, Jinju, South Korea.ORCID 0000-0002-4598-5371
Eun-Kyeong JoDepartment of Microbiology, Chungnam National University School of Medicine, Daejeon, South Korea.ORCID 0000-0001-7191-0587
Chungnam National University · KRGyeongsang National University · KRSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ohmyungsamycin A (OMS) is a newly identified cyclic peptide that exerts antimicrobial effects against

Indexed as

Mycobacterium abscessusMycobacterium Infections, NontuberculousAnimalsAnti-Bacterial AgentsHumansMacrophagesMiceZebrafishAnti-Bacterial Agentsinnate immunityM1 macrophage responsesmitochondrial reactive oxygen speciesMycobacteroides abscessusnitric oxideOhmyungsamycins

Identifiers

PMID36271707
PMCPMC9673965
OpenAlexW4307093574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.